Shell Asset Management CO Precigen, Inc. Transaction History

Shell Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.15 - $2.53 $21,985 - $48,368	-19,118 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$1.91 - $3.98 $5,489 - $11,438	-2,874 Reduced 13.07%	19,118 $40,000
Q4 2021 Feb 09, 2022	SELL	$3.53 - $5.5 $1,369 - $2,134	-388 Reduced 1.73%	21,992 $82,000
Q3 2021 Nov 04, 2021	SELL	$4.99 - $6.55 $4,341 - $5,698	-870 Reduced 3.74%	22,380 $112,000
Q1 2021 May 10, 2021	BUY	$6.74 - $10.95 $156,705 - $254,587	23,250 New	23,250 $160,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.